Fox, L.C.; Yannakou, C.K.; Ryland, G.; Lade, S.; Dickinson, M.; Campbell, B.A.; Prince, H.M.
Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy. Int. J. Mol. Sci. 2018, 19, 1758.
https://doi.org/10.3390/ijms19061758
AMA Style
Fox LC, Yannakou CK, Ryland G, Lade S, Dickinson M, Campbell BA, Prince HM.
Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy. International Journal of Molecular Sciences. 2018; 19(6):1758.
https://doi.org/10.3390/ijms19061758
Chicago/Turabian Style
Fox, Lucy C., Costas K. Yannakou, Georgina Ryland, Stephen Lade, Michael Dickinson, Belinda A. Campbell, and Henry Miles Prince.
2018. "Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy" International Journal of Molecular Sciences 19, no. 6: 1758.
https://doi.org/10.3390/ijms19061758
APA Style
Fox, L. C., Yannakou, C. K., Ryland, G., Lade, S., Dickinson, M., Campbell, B. A., & Prince, H. M.
(2018). Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy. International Journal of Molecular Sciences, 19(6), 1758.
https://doi.org/10.3390/ijms19061758